Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Validation of ASTN1, DLX1, ITGA4, RXFP3, SOX17, ZNF671 Methylation in HPV Positive Women: a Multi-center RCT From China

NCT06366516 is registered in ClinicalTrials.gov with Obstetrics & Gynecology Hospital of Fudan University as lead sponsor.

NCT NCT06366516
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06366516 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Validation of ASTN1, DLX1, ITGA4, RXFP3, SOX17, ZNF671 Methylation in HPV Positive Women: a Multi-center RCT From China
Lead sponsor
Obstetrics & Gynecology Hospital of Fudan University
Phase
Not applicable
Overall status
Unknown status
Start date
April 30, 2024
Completion date
February 28, 2026
Enrollment
10,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

precancerous cervical lesion